The Company continues a business project to implement an automated manufacturing control system based on SAP ERP. Implementation of the integrated management information system based on SAP will enable the Company to perform all operations, providing life-cycle products, as well as the accounting for such transactions into a single information environment that will enhance the handling of all processes, and most importantly - the quality of the products.
Development and introduction of new products, extension of the formulation range and dosage forms in order to meet market demands and customersХ expectations
Enhancement of manufacturing localization through joint projects with leading international pharmaceutical companies
Extension of Company`s product portfolio with high-margin pharmaceuticals
Expand Pharmstandard participation in the state import substitution program
Automation of production planning processes in order to increase efficiency of process management and strengthen cost control
Within the frames of its strategic development the Company invests heavily in development and upgrade of its manufacturing facilities.
In the near term, the following manufacturing sites will be commissioned:
